U.S. Markets closed

A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says

Teresa Rivas

Cantor’s Louise Chen says the potential for Merck’s Keytruda in China could equate to billions of dollars not yet in forecasts.